AIM 3 Sample Clauses

AIM 3 i. We will continue working to identify meaningful discoveries (not only medical product candidates, but technologies developed in all of our scientific disciplines across our three UM campuses (e.g. engineering, medicine, physics, marine biology, etc.) and help research teams to develop them, and to advance those discoveries through all the stages required toward commercialization.

AIM 3 a. The RTS-Smartstore DNA storage robotic system, within the Hussman Institute Biorepository is now fully operational and implemented into the Nautilus LIMs system.

AIM 3. Both the Division (1.a above) and the Prevention Science and Methodology Group (PSMG) provide organizational support for this goal. The PSMG network, established 10 years ago and comprising more than 170 researchers and methodologists, conducts interdisciplinary methods presentations through weekly grand-rounds conference calls and facilitatesmethodological development and application in leading edge research nationally. Xx. Xxxxx heads this group, and Xx. Xxxxxxxxx has joined PSMG's steering committee so that it can address the Miami CTSI agenda for developing translational biostatistics research. This Component has also created a small grant program to stimulate cross-school collaborations in methodological development.

AIM 3. We plan to produce a paper on Scientific Equity that maps out design requirements for randomized trials of interventions and strategies for synthesizing findings from the literature related to health disparities. We, along with our collaborators, plan to submit an NIH application to develop the biostatistical and psychometric methodology for extending computerized adaptive testing to minority populations. This method would identify items that display differential item functioning as well as different underlying psychometric structures. We plan to submit this as an extension of measuring depressive, anxious, and bipolar symptoms in a Spanish speaking population as a model that can be generalized to other medical conditions and populations.

AIM 3. To develop degree-granting and formal early career mentored programs that will expand and diversify the research workforce, with a particular focus on addressing health care disparities and culturally appropriate research methods.

AIM 3. Our trainee, Dr. Xxxxx Kenya was selected as one of the four initial CTSI pilot trainees. Her project focuses on use home based Rapid HIV testing as a means to increase HIV screening in underserved African-American communities, one of the priority areas highlighted by the CTSI Community Advisory Board. Medical Student Xxxxxx Xxxxxx, building on a project showing high rates of dirty needles in Miami due to lack of needle exchange programs (another CAB identified community priority), has spearheaded a medical student led State-Wide campaign to write and introduce House and Senate bills in FL allowing for needle exchange programs in the state. This initiative has garnered 500 hours of service from the Florida Medical Association, the full support of our University’s lobbyists, support from over 10 State-wide organizations, Bills introduced in the State House and Senate and committee hearings.

AIM 3. Examine Transition Assessment Literature & Identify Transition Factors From the literature search and review, 6 studies evaluating the success of transition and identifying challenges to transition were found to be relevant. These papers were used as the basis for extracting and categorizing common factors affecting a successful transition process. The criteria for including the factors were that 1) the factor was identified in at least one paper, 2) the factor was considered by the authors to be an important yet not adequately considered in the transition assessments run by Gavi or Global Fund, and 3) it is a factor not taken into consideration in the current Eligibility, Transition, and Co-financing Policies of Gavi or the Global Fund. These factors were then organized in Microsoft Excel to roughly represent the frequency and the time period in which these factors began to be analyzed, and whether their analysis recurred in subsequent papers. Table 5 shows a simple list of the identified factors from these 6 papers.